Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial

The biotech company is the first to release positive phase three data on a Covid and flu combination shot, giving it a potential lead over rival vaccine makers Pfizer and Novavax. Bancel added that combination shots could reduce the burden of respiratory viruses on pharmacists and the broader U.S. health-care system, which has been grappling with a labor shortage that has many workers stretched thin. The study compared the combination shot with an enhanced flu vaccine called Fluzone HD and Moderna's current ...